DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 7,732,183 B2 Tomasselli Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 7,732,183 B2 Tomasselli Et Al US007732183B2 (12) United States Patent (10) Patent No.: US 7,732,183 B2 Tomasselli et al. (45) Date of Patent: *Jun. 8, 2010 (54) METHOD FOR REFOLDING ENZYMES Mallender, William; Characterization of Recombinant, Soluble B-Secretase from an Insect Cell Expression System, Molecular Phar (75) Inventors: Alfredo Tomasselli, Kalamazoo, MI macology: 59: 619-626, 2001. (US); Robert Heinrikson, Plainwell, MI Benjannet, Suzanne, et al; Post-translational Processing of f3 Secretase (3-Amyloid-converting Enzyme) and its Ectodomain (US); Donna Paddock, Kalamazoo, MI Shedding: The Journal of Biological Chemistry, vol. 276, No. 14. (US); Ana Mildner, Kalamazoo, MI Apr. 6.2001; 10879-10887. (US); Thomas Emmons, Portage, MI Capell, Anja, et al; Maturation of Pro-peptide Cleavage of (US) B-Secretase, The Journal of Biological Chemistry, vol. 275, No. 40, Oct. 6, 2000; pp. 30849-30854. (73) Assignee: Elan Pharmaceuticals, Inc., South San Charlwood, Joanne, et al; Characterization of the Blycosylation Pro Francisco, CA (US) files of Alzheimer's B-Secretase Protein Asp-2 Expressed in a Vari ety of Cell Lines; The Journal of Bioological Chemistry, vol. 276, No. (*) Notice: Subject to any disclaimer, the term of this 20, May 18, 2001; p. 16739-16748. patent is extended or adjusted under 35 Ermolieff, Jacques, et al; Proteolytic Activation of Recombinant U.S.C. 154(b) by 547 days. Pro-memapsin 2 (Pro-B-secretase) Studied with New Fluorogenic Substrates: Biochemistry 2000, 39, 12450-12456. This patent is Subject to a terminal dis Haniu, Mitsuru, et al; Chracterization of Alzheimer's B-Secretase claimer. Protein BACE. The Journal of Biological Chemistry; vol. 275, No. 28, Jul. 14, 2000: pp. 21099-21 106. (21) Appl. No.: 11/703,493 Hussain, Ishrut, etal; Identification of a Novel Aspartic Protease (Asp 2)as B Secretase, Molecular and Cellular Neuroscience; 14. 419 (22) Filed: Feb. 7, 2007 427 (1999). Khan, Amir, et al; Molecular mechanisms for the convesion of (65) Prior Publication Data zymogens to active proteolytic enzymes, Protein Science (1998) T:815-836. US 2009/0053787 A1 Feb. 26, 2009 Lin, Xinli, et al; Rearranging the domains of pepsinogen, (1995), 4:159-166. Related U.S. Application Data Lin, Xin-Li, et al; Synthesis, Purification, and Active Site Mutagenesis of Recombinant Procine Pepsinogen, The Journal of (63) Continuation of application No. 10/230,677, filed on Biological Chemistry; vol. 264, No. 8, Mar. 15, 1989: pp. 4482-4489. Aug. 29, 2002, now Pat. No. 7,186,539. Lin, Xinli, et al.; Human aspartic proteas emeapsin 2 cleaves the (60) Provisional application No. 60/316,934, filed on Aug. B -amyloid precursor protein; PNAS, Feb. 15, 2000; vol. 97, pp. 31, 2001. 1456-1460. Mildner, Ana, et al; Production of Chemokines CTAPIII and NAP/2 (51) Int. Cl. by Digestion of Recombinant Ubiquitin-CTAPIII with Yeast CI2N 9/50 (2006.01) Ubiquitin C-Terminal Hydrolase and Human Immunodeficiency Virus Protease, Protein Expression and Purification vol. 16,347-354 (52) U.S. Cl. ....................................... 435/219; 435/226 (1999). (58) Field of Classification Search ....................... None Selkoe, D.J., Cell Biology of the B–Amyloid Precursor Protein and See application file for complete search history. the Genetics of alzheimer's Disease; Cold Spring Harbor Symposia (56) References Cited on Quantatative Biology, vol. LXI, 1996, pp. 587-596. Selkoe, Dennis J.; translating cell biology into therapeutic advances U.S. PATENT DOCUMENTS in Alzheimer's disease, Nature, vol. 399, Jun. 24, 199 pp. A23-A31. 5,744,346 A 4/1998 Chrysler et al. (Continued) 6,319,689 B1 1 1/2001 Powell et al. 6,323,326 B1 1 1/2001 Dorin et al. Primary Examiner Nashaat T Nashed 6,545,127 B1 4/2003 Tang et al. (74) Attorney, Agent, or Firm McDonnell Boehnen 6,583,268 B2 6, 2003 Lin Hulbert & Berghoff LLP FOREIGN PATENT DOCUMENTS (57) ABSTRACT WO 9822597 5, 1998 WO OO17369 3, 2000 WO OO47617 8, 2000 The invention provides methods for efficient recombinant WO O1OO663 1, 2001 expression, refolding, and purification of Beta-site APP WO O 123533 4/2001 cleaving enzyme (BACE) polypeptides. In various aspects, the method includes the steps of expressing a recombinant OTHER PUBLICATIONS constructin bacteria, dissolving inclusion bodies with a dena Yan, Riciang, et al.; Membrane-anchored aspartyl protease with turant at high pH in the presence of a reducing agent, diluting Alzheimer's disease B secretase activity; Nature, vol. 402, Dec. 2, the solubilized BACE polypeptide in an aqueous solutionata 1999. temperature of about 1° C. to 15° C., and incubating the Vassar, Robert, et al; B-Secretase Cleavage of Alzheimer's Amyloid diluted sample at a temperature of about 4°C. to 15°C. until Precursor Protein by the Transmembrane Aspartic Protease BACE: the recombinant BACE polypeptide folds into an active Science, vol. 286, Oct. 22, 1999. Sinha, Sukanto, et al; Purification and cloning of amyloid precursor enzyme. protein B–secretase from human brain, Nature, vol. 402, (6761):537-540. 24 Claims, 15 Drawing Sheets US 7,732,183 B2 Page 2 OTHER PUBLICATIONS Schechter, Israel, et al; On the Size of the Active Site in Proteases. I Papain, Biochemical and Biophysical Research Communications, Thinakaran, Gopal, et al; Metabolis of the "Swedish 'Amyloid Pre vol. 27, No. 2, 1967; pp. 157-162. cursor Protein Variant in Neuro 2a (N2a) Cells, the Journal of Bio Shi, Xiao-Ping, etal; The Pro Domain of B-Secretase does not Confer logical Chemistry; vol. 271, No. 16, Apr. 19, 1996; pp. 9390-9397. Strict Zymogen-like Properties but Does Assit Proper Folding of the Hong, L. et al.; Structure of the protease domain of memapsin 2 Protease Domain, vol. 276, No. 13, 2001; pp. 10366-10373. (beta-secretase) complexed with inhibitor; Science 2000; 290(5489), Heinrikson, Robert L. etal; The Biochemistry and Molecular Biology 150-3. of Recombinant Human Renin and Prorenin, Hypertension: Heinrikson, R.L., et al; The Biochemistry and molecular biology of Pathophysiology, Diagnosis and Management; 1990; pp. 1179-1196. recombinant rennin and proorenin, Hypertension: Pathophysiology, Hong, Lin, et al; Structure of the Protease Domain of Memapsin2 Diagnosis and management 1990; chapter 74:1179-1196. (B-Secretase) Complexed with Inhibitor; Science Magazine, vol. 290, Shi, X-P, et al; The pro domain of -secretase does not confer strict Oct. 6, 2000; pp. 150-153. Zymogen-like properties but assist proper refolding of the protease Selkoe, Dennis, J.; Alzheimer's Disease. Genes, Proteins and domain; J. Biol. Chem 2001; 267: 10366-10373. Therapy; Physiological Review, vol. 81, No. 2, Apr. 2001, pp. 741 Inagami, T. etal; Biomed Res. 1980; 1:456-475. T66. U.S. Patent Jun. 8, 2010 Sheet 10 of 15 US 7,732,183 B2 *****************{3#ž**$3&#####33333.3%,g. {3; ; , S: U.S. Patent Jun. 8, 2010 Sheet 11 of 15 US 7,732,183 B2 G. s. U.S. Patent Jun. 8, 2010 Sheet 12 of 15 US 7,732,183 B2 & - s : : * *: s : 8 : 88: ... -- pit-is-(i. S.S. & E is :::cti:388 8: post-BACE (R.S. Parification Steps. U.S. Patent Jun. 8, 2010 Sheet 13 of 15 US 7,732,183 B2 U.S. Patent Jun. 8, 2010 Sheet 15 Of 15 US 7,732,183 B2 : exities expresseti i r is casts: pist. .x.O., inciating treates with two protease. US 7,732,183 B2 1. 2 METHOD FOR REFOLDING ENZYMES BACE isolated from human brain is heavily glycosylated. As expressed by a stably transfected 293T cell line, BACE is CROSS-REFERENCE TO RELATED glycosylated at four asparagines: 132, 151, 202, and 333. APPLICATIONS Analysis of HEK 293 cells stably overexpressing BACE showed that the enzyme is phosphorylated at Ser477, and that This application is a continuation of U.S. patent applica phosphorylation regulates enzyme intracellular trafficking tion Ser. No. 10/230,677, filed Aug. 29, 2002, which claims (Walter et. al., 2001, J. Biol. Chem. 276:14634-41). Three the benefit of U.S. Provisional Patent Application Ser. No. disulfide bonds suggested as critical for activity, are formed 60/316,934, filed Aug. 31, 2001. between the following pairs of cysteine residues: Cys 195 10 Cys399, Cys257-Cys422, and Cys309-Cys359 (Haniu et al., FIELD OF THE INVENTION 2000, J. Biol. Chem. 275:21099-21106). These structural features of the BACE polypeptide all The invention relates generally to recombinant expression, appear to have specific functions relating to enzymatic activ refolding, and purification of an enzyme. More particularly, ity. Enzymes expressed in insect and CHO cells are properly the invention relates to novel methods for preparing purified, 15 refolded and show activity. These proteins are glycosylated. active, human BACE expressed in E. coli. For example, insect cells express glycosylated BACE, from the mannose-rich glycans available in the insect cells. Bian BACKGROUND OF THE INVENTION tennary and triantennary oligosaccharides of the complex type provide glycosylation in the CHO-expressed BACE Neuritic plaques containing primarily amyloid beta protein (Charlwoodet. al., 2001 J. Biol. Chem. 276:16739-48). These (Abeta) are one of the hallmarks of Alzheimer's Disease. glycosylated proteins have proven difficult to process, how Beta-site APP cleaving enzyme (BACE), known also as beta ever, due to the heterogeneity conferred by differential gly secretase, Asp2, and Memapsin, has been identified as the cosylation. BACE production in these cells generally requires enzyme responsible for processing amyloid precursorprotein expensive culture media and does not yield high amounts of (APP) to produce the N-terminal portion of the Abeta peptide. 25 protein. This enzyme has been suggested as rate limiting in the pro These negative aspects of mammalian and insect cell duction of the Abeta peptide. See, for example, Sinha et al., expression do not apply to BACE proteins expressed in E.
Load more

Recommended publications
  • Analyse Structurale Et Fonctionnelle De La Préséniline-1 Humaine : Implications Dans La Maladie D'alzheimer
    SÉBASTIEN HÉBERT ANALYSE STRUCTURALE ET FONCTIONNELLE DE LA PRÉSÉNILINE-1 HUMAINE : IMPLICATIONS DANS LA MALADIE D’ALZHEIMER Thèse présentée à la Faculté des études supérieures de l’Université Laval dans le cadre du programme de biologie cellulaire et moléculaire pour l’obtention du grade de Philosophiae Doctor (Ph.D.) FACULTÉ DE MÉDECINE UNIVERSITÉ LAVAL QUÉBEC DÉCEMBRE 2003 © Sébastien S. Hébert, 2003 i RÉSUME COURT La préséniline-1 (PS1) mutée est associée à un développement très précoce de la maladie (chez les individus de 24-55 ans) d’Alzheimer. Dans la cellule, la PS1 existe principalement sous forme de fragments (N-terminaux et C-terminaux, respectivement NTFs et CTFs) qui semblent nécessaires à sa fonction et à l’activité γ- secrétase étroitement liée à la formation des peptides β-amyloïdes neurotoxiques. Nous avons étudié l’organisation structurale et fonctionnelle de la PS1, ses fragments, et leurs relations avec les protéines impliquées dans la production des peptides β- amyloïdes. Dans un premier temps, des expériences en levure, confirmées avec des techniques d’immunobuvardage et d’immunoprécipitation en cellules de mammifères, nous ont permis de mettre en évidence un rôle de l’holoprotéine de la PS1 dans la génération des fragments NTFs et CTFs. De plus, il a été possible de démontrer une interaction directe entre PS1 et BACE (enzyme de type aspartyl protéase aussi appelée β-secrétase), les deux joueurs clés dans la production des peptides β- amyloïdes. Finalement, l’étude du rôle fonctionnel de cette interaction nous a fournis des résultats permettant de suggérer une régulation de la PS1 par BACE.
    [Show full text]
  • 2006.01) Kr, Kw, Kz, La, Lc, Lk, Lr, Ls, Lu, Ly, Ma, Md, Me, (21
    ( (51) International Patent Classification: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, A61K 48/00 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US20 19/06 1701 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 15 November 2019 (15. 11.2019) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available) . ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/768,645 16 November 2018 (16. 11.2018) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 62/769,697 20 November 2018 (20. 11.2018) US EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, 62/778,706 12 December 2018 (12. 12.2018) US MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, Cl, CM, GA, GN, GQ, GW, (71) Applicant: ASKLEPIOS BIOPHARMACEUTICAL, KM, ML, MR, NE, SN, TD, TG).
    [Show full text]
  • DUAL ROLE of CATHEPSIN D: LIGAND and PROTEASE Martin Fuseka, Václav Větvičkab
    Biomed. Papers 149(1), 43–50 (2005) 43 © M. Fusek, V. Větvička DUAL ROLE OF CATHEPSIN D: LIGAND AND PROTEASE Martin Fuseka, Václav Větvičkab* a Institute of Organic Chemistry and Biochemistry, CAS, Prague, Czech Republic, and b University of Louisville, Department of Pathology, Louisville, KY40292, USA, e-mail: [email protected] Received: April 15, 2005; Accepted (with revisions): June 20, 2005 Key words: Cathepsin D/Procathepsin D/Cancer/Activation peptide/Mitogenic activity/Proliferation Cathepsin D is peptidase belonging to the family of aspartic peptidases. Its mostly described function is intracel- lular catabolism in lysosomal compartments, other physiological effect include hormone and antigen processing. For almost two decades, there have been an increasing number of data describing additional roles imparted by cathepsin D and its pro-enzyme, resulting in cathepsin D being a specific biomarker of some diseases. These roles in pathological conditions, namely elevated levels in certain tumor tissues, seem to be connected to another, yet not fully understood functionality. However, despite numerous studies, the mechanisms of cathepsin D and its precursor’s actions are still not completely understood. From results discussed in this article it might be concluded that cathepsin D in its zymogen status has additional function, which is rather dependent on a “ligand-like” function then on proteolytic activity. CATHEPSIN D – MEMBER PRIMARY, SECONDARY AND TERTIARY OF ASPARTIC PEPTIDASES FAMILY STRUCTURES OF ASPARTIC PEPTIDASES Major function of cathepsin D is the digestion of There is a high degree of sequence similarity among proteins and peptides within the acidic compartment eukaryotic members of the family of aspartic peptidases, of lysosome1.
    [Show full text]
  • A Novel Thermostable Aspartic Protease from Talaromyces Leycettanus and Its Specific
    bioRxiv preprint doi: https://doi.org/10.1101/528265; this version posted January 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 1 RESEARCH ARTICLE 2 3 A novel thermostable aspartic protease from Talaromyces leycettanus and its specific 4 autocatalytic activation through an intermediate transition state 5 6 Yujie Guo1, Tao Tu1, Yaxin Ren1, Yaru Wang1, Yingguo Bai1, Xiaoyun Su1, Yuan 7 Wang1, Bin Yao1, Huoqing Huang1*, Huiying Luo1* 8 9 1Key Laboratory for Feed Biotechnology of the Ministry of Agriculture, Feed Research 10 Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, P. R. China 11 Running title: Insights into a specific auto-activation of proTlAPA1 12 * Corresponding authors. 13 E-mail addresses: [email protected] (H. Luo), [email protected] (H. Huang). 2 bioRxiv preprint doi: https://doi.org/10.1101/528265; this version posted January 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 14 ABSTRACT 15 Aspartic proteases exhibit optimum enzyme activity under acidic condition and 16 have been extensively used in food, fermentation and leather industries. In this study, 17 a novel aspartic protease precursor (proTlAPA1) from Talaromyces leycettanus was 18 identified and successfully expressed in Pichia pastoris. Subsequently, the 19 auto-activation processing of the zymogen proTlAPA1 was studied by SDS-PAGE 20 and N-terminal sequencing, under different processing conditions. TlAPA1 shared the 21 highest identity of 70.3 % with the aspartic endopeptidase from Byssochlamys 22 spectabilis (GAD91729) and was classified into a new subgroup of the aspartic 23 protease A1 family, based on evolutionary analysis.
    [Show full text]
  • Multiple Functions of Pro-Parts of Aspartic Proteinase Zymogens
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 343 (1994) 6-10 ELSEVIER FEBS 13889 Minireview Multiple functions of pro-parts of aspartic proteinase zymogens Gerald Koelsch”, Michael MareSb, Peter Metcalf”, Martin FusekaT* ~~k~ahornaMedical Research ~~~n~t~on and Un~Qer~ityof Oklahoma Hearth Sciences Center, 825 N.E. 13th Street, Oklahoma City, OK 73f04, USA ‘institute of Organic Chem~try and Ei~c~~rn~~r~,Czech Academy of Sciences, Prague, CZ 16~~~~Czech Republic “European Molecular Bioiogy Laboratory, Heidelberg, D-6900, Germany Received 4 March 1994 Abstract The importance of aspartic proteinases in human pathophysiology continues to initiate extensive research. With burgeoning information on their biological functions and structures, the traditional view of the role of activation peptides of aspartic proteinases solely as inhibitors of the active site is changing. These peptide segments, or pro-parts, am deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. Consequently, the primary structures of pro-parts reflect these functions. We discuss guidelines for formation of hypotheses derived from comparing the physiological function of aspartic proteinases and sequences of their pro-parts. Key words: Aspartic proteinase; Chaperon; Folding; Pro-part; Protein structure; Targeting 1. Introduction teinases starts with the removal of their signal peptides during the passage into the endoplasmic reticulum. The Aspartic proteinases (EC 3.4.23) share a high degree complete activation of eucaryotic zymogens of aspartic of similarity which involves primary structures, extend- proteinases is accomplished by a proteolytic removal of ing through almost identical secondary structural motifs the N-terminal pro-part which is usually 44-50 amino and manifesting a typical bilobal molecular shape [1,2].
    [Show full text]
  • Demonstration of Pepsinogen C in Human Pancreatic Islets
    Gut: first published as 10.1136/gut.28.10.1208 on 1 October 1987. Downloaded from Gllt, 1987, 28, 1208- 1214 Alimentary tract and pancreas Demonstration of pepsinogen C in human pancreatic islets P B SZECSI, LI HALGREEN, SS POULSEN, C K AXELSSON, M DAMKJ/ER-NIELSEN, T KJ/ER, AND B FOLTMANN From The Department of Clinical Chemistry, Hvidovre Hospital; Institute of Pathology, Bispebjerg Hospital; Institute of Biochemical Genzetics, In.stituite of Medical Anatomy, Departnzent B and Department of Clinical Physiology, Glostrup Hospital, University of Copenhagen. Department K of Surgery, Vejle Hospital and Department L ofSurgery, Arhu.s Municipal Hospital, University ofArhus, Denmark. SUMMARY Pancreatic tissue from 16 post mortem kidney donors have been examined for the content of pepsinogens. A zymogen with electrophoretic mobility, isoelectric point and molecular weight equal to that of pepsinogen C of gastric origin was found in all specimens. A comparison between pepsinogen C extracted from pancreatic tissue and gastric mucosa demonstrated immunological identity. Quantitative measurements with a radioimmunoassay showed pepsinogen C concentrations in pancreatic tissue three to 80 times higher than those of blood serum. Immunohistochemical staining gave positive reaction for pepsinogen C only in the alpha cells of the pancreatic islets. http://gut.bmj.com/ Gastric proteases belong to the superfamily of superfamily of aspartic proteases localised outside aspartic proteases (EC 3.4.23). The predominant the gastrointestinal tract have traditionally been gastric proteases of adult mammals are designated designated cathepsin D or E.'" During a series of pepsin A (EC 3.4.23.1) and pepsin C (EC 3.4.23.3).
    [Show full text]
  • Chitin Digestibility Is Dependent on Feeding Behaviors, Which Determine Acidic Chitinase Mrna Levels in Mammalian and Poultry St
    www.nature.com/scientificreports OPEN Chitin digestibility is dependent on feeding behaviors, which determine acidic chitinase mRNA Received: 20 October 2017 Accepted: 10 January 2018 levels in mammalian and poultry Published: xx xx xxxx stomachs Eri Tabata1, Akinori Kashimura1, Azusa Kikuchi1, Hiromasa Masuda1, Ryo Miyahara1, Yusuke Hiruma1, Satoshi Wakita1, Misa Ohno1, Masayoshi Sakaguchi1, Yasusato Sugahara1, Vaclav Matoska2, Peter O. Bauer2,3 & Fumitaka Oyama 1 Chitin, a polymer of N-acetyl-D-glucosamine (GlcNAc), functions as a major structural component in chitin-containing organism including crustaceans, insects and fungi. Recently, we reported that acidic chitinase (Chia) is highly expressed in mouse, chicken and pig stomach tissues and that it can digest chitin in the respective gastrointestinal tracts (GIT). In this study, we focus on major livestock and domestic animals and show that the levels of Chia mRNA in their stomach tissues are governed by the feeding behavior. Chia mRNA levels were signifcantly lower in the bovine (herbivores) and dog (carnivores) stomach than those in mouse, pig and chicken (omnivores). Consistent with the mRNA levels, Chia protein was very low in bovine stomach. In addition, the chitinolytic activity of E. coli-expressed bovine and dog Chia enzymes were moderately but signifcantly lower compared with those of the omnivorous Chia enzymes. Recombinant bovine and dog Chia enzymes can degrade chitin substrates under the artifcial GIT conditions. Furthermore, genomes of some herbivorous animals such as rabbit and guinea pig do not contain functional Chia genes. These results indicate that feeding behavior afects Chia expression levels as well as chitinolytic activity of the enzyme, and determines chitin digestibility in the particular animals.
    [Show full text]
  • Evolution of Digestive Enzymes and Dietary Diversification in Birds
    Evolution of digestive enzymes and dietary diversification in birds Yan-Hong Chen and Huabin Zhao Department of Ecology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China ABSTRACT As the most species-rich class of tetrapod vertebrates, Aves possesses diverse feeding habits, with multiple origins of insectivory, carnivory, frugivory, nectarivory, granivory and omnivory. Since digestive enzymes mediate and limit energy and nutrient uptake, we hypothesized that genes encoding digestive enzymes have undergone adaptive evolution in birds. To test this general hypothesis, we identified 16 digestive enzyme genes (including seven carbohydrase genes (hepatic amy, pancreatic amy, salivary amy, agl, g6pc, gaa and gck), three lipase genes (cyp7a1, lipf and pnlip), two protease genes (ctrc and pgc), two lysozyme genes (lyz and lyg) and two chitinase genes (chia and chit1)) from the available genomes of 48 bird species. Among these 16 genes, three (salivary amy, lipf and chit1) were not found in all 48 avian genomes, which was further supported by our synteny analysis. Of the remaining 13 genes, eight were single-copy and five (chia, gaa, lyz, lyg and pgc) were multi-copy. Moreover, the multi- copy genes gaa, lyg and pgc were predicted to exhibit functional divergence among copies. Positively selected sites were detected in all of the analyzed digestive enzyme genes, except agl, g6pc, gaa and gck, suggesting that different diets may have favored differences in catalytic capacities of these enzymes. Furthermore, the analysis also revealed that the pancreatic amylase gene and one of the lipase genes (cyp7a1) have higher ! (the ratio of nonsynonymous to the synonymous substitution rates) values in species consuming a larger amount of seeds and meat, respectively, indicating an intense selection.
    [Show full text]
  • Molecular and Evolutionary Basis for Survival, Its Failure, And
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.12.435207; this version posted March 13, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Good host - bad host: molecular and evolutionary basis for survival, its failure, and virulence factors 2 of the zoonotic nematode Anisakis pegreffii 3 4 5 6 7 Željka Trumbić1, Jerko Hrabar2, Nikola Palevich3, Vincenzo Carbone3, Ivona Mladineo4* 8 9 1University Department of Marine Studies, University of Split, 21000 Split, Croatia 10 2Laboratory of Aquaculture, Institute of Oceanography & Fisheries, 21000 Split, Croatia 11 3AgResearch Limited, Grasslands Research Centre, Palmerston North, 4410, New Zealand 12 4Laboratory of Functional Helminthology, Institute of Parasitology, Biology Centre of Czech Academy of 13 Science, 37005 Ceske Budejovice, Czech Republic 14 15 16 17 corresponding author: [email protected] 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.12.435207; this version posted March 13, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 49 Abstract 50 Parasitism is a highly successful life strategy and a driving force in genetic diversity that has evolved many 51 times over.
    [Show full text]
  • Molecular Cloning and the Nucleotide Sequence of Cdna for Embryonic Chicken Pepsinogen: Phylogenetic Relationship with Prochymosin1
    J. Biochem. 103, 290-296 (1988) Molecular Cloning and the Nucleotide Sequence of cDNA for Embryonic Chicken Pepsinogen: Phylogenetic Relationship with Prochymosin1 Kensuke Hayashi, * Kiyokazu Agata, * * Makoto Mochii, * * Sadao Yasugi, * Goro Eguehi, and Takeo Mizuno* *Zoological Institute , Faculty of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113; and **Department of Developmental Biology, National Institute for Basic Biology, Okazaki, Aichi 444 Received for publication, September 17, 1987 Embryonic chicken pepsinogen is an aspartyl proteinase that is specifically secreted during the embryonic period in the chicken proventriculus (glandular stomach). To learn the phylogeny of this pepsinogen, we isolated a eDNA clone by screening a Agtll library of embryonic proventricular cDNAs with an antiserum to the embryonic chicken pepsinogen. We obtained a 200-base pair cDNA clone which encoded 18 amino acids that had high sequence homology with the carboxyl termini of other pepsinogens. Northern blot analysis revealed that this eDNA clone hybridized to a mRNA of 1,600 bases in the embryonic proventriculus but not to the mRNA in the adult proventriculus. The almost complete nucleotide sequence of embryonic chicken pepsinogen-cDNA was determined by sequenc ing longer cDNAs obtained by screening the same library with the 200-base pair eDNA and primer extension with a synthetic primer. The cDNA consisted of 1,281 nucleotides and encoded 383 amino acids for prepepsinogen. The predicted amino acid sequence was compared with the sequences of other aspartyl proteinases: pepsinogen A of human, monkey, pig, and chicken, progastricsin of monkey and rat, and bovine prochymosin. The phylogenetic tree constructed for them indicates the possibility that embryonic chicken pepsinogen diverged from prochymosin, after prochymosin and pepsinogen A had diverged from each other.
    [Show full text]
  • Exogenous Enzymes in Animal Nutrition – Benefits and Limitations
    Animal Nutrition and Feed Technology Volume 13 Number 3 September 2013 Special Issue EXOGENOUS ENZYMES IN ANIMAL NUTRITION – BENEFITS AND LIMITATIONS Guest Editor A.Z.M. Salem Facultad de Medicina Veterinaria y Zootecnia Universidad Autónoma del Estado de México, México and N. Odongo Animal Production and Health Section International Atomic Energy Agency, Vienna, Austria Animal Nutrition Association Indian Veterinary Research Institute, Izatnagar‐243 122, India www.anft.org Animal Nutrition and Feed Technology Volume 13 Number 3 September 2013 CONTENTS Special Issue: Exogenous Enzymes In Animal Nutrition - Benefits And Limitations Preface 34. A.Z.M. SALEM, N. ODONGO AND A.K. PATTANAIK Exogenous Enzymes in Animal Nutrition- Benefits and Limitations 335 In vivo Studies 35. D.B. DEAN, C.R. STAPLES, R.C. LITTELL, S. KIM AND A.T. ADESOGAN Effect of Method of Adding a Fibrolytic Enzyme to Dairy Cow Diets on Feed Intake Digestibility, Milk Production, Ruminal Fermentation, and Blood Metabolites 337 36. A. LARA BUENO, G.D. MENDOZA MARTÍNEZ, P.A. HERNÁNDEZ GARCÍA, J.A. MARTÍNEZ GARCÍA AND F.X. PLATA PÉREZ Evaluation of High Doses of Exogenous Fibrolytic Enzymes in Lambs Fed an Oat Straw Based Ration 355 37. O. ARCE-CERVANTES, G.D. MENDOZA, P.A. HERNÁNDEZ, M. MENESES, N. TORRES-SALADO AND O. LOERA The Effects of a Lignocellulolytic Extract of Fomes sp. EUM1 on the Intake, Digestibility, Feed Efficiency and Growth of Lambs 369 38. J.A. CAYETANO, A.Z.M. SALEM, B.M.A. MARIEZCURRENA, R. ROJO, M.A. CERRILLO-SOTO, H. GADO AND L.M. CAMACHO Effect of adding Salix babylonica Extracts and Exogenous Enzymes to Basal Diets on the Meat Quality of Growing Suffolk Lambs 373 39.
    [Show full text]
  • Structure and Function of Plant Aspartic Proteinases
    Eur. J. Biochem. 271, 2067–2075 (2004) Ó FEBS 2004 doi:10.1111/j.1432-1033.2004.04136.x REVIEW ARTICLE Structure and function of plant aspartic proteinases Isaura Simo˜ es and Carlos Faro Departamento de Biologia Molecular e Biotecnologia, Centro de Neurocieˆncias e Biologia Celular, Universidade de Coimbra and Departamento de Bioquı´mica, Faculdade de Cieˆncias e Tecnologia, Universidade de Coimbra, Portugal Aspartic proteinases of the A1 family are widely distributed processing and is absent from the mature form of the among plant species and have been purified from a variety enzyme. Its functions are still unclear but a role in the vac- of tissues. They are most active at acidic pH, are specifically uolar targeting of the precursors has been proposed. The inhibited by pepstatin A and contain two aspartic residues biological role of plant aspartic proteinases is also not indispensible for catalytic activity. The three-dimensional completely established. Nevertheless, their involvement in structure of two plant aspartic proteinases has been deter- protein processing or degradation under different conditions mined, sharing significant structural similarity with other and in different stages of plant development suggests some known structures of mammalian aspartic proteinases. With functional specialization. Based on the recent findings on the a few exceptions, the majority of plant aspartic proteinases diversity of A1 family members in Arabidopsis thaliana,new identified so far are synthesized with a prepro-domain and questions concerning novel structure–function relationships subsequently converted to mature two-chain enzymes. A among plant aspartic proteinases are now starting to be characteristic feature of the majority of plant aspartic pro- addressed.
    [Show full text]